Open AccessPeer ReviewedPublished Monthly Since 2007 Vol. 19, Issue 12 · November 2026Media Kitinfo@guident.net

Dental Complications After COVID-19- Understanding the Pathophysiology: Case Series Part-3

  • Dr. Gaurav GuptaPrivate Practice
  • Dr. D.K. GuptaConsultant
  • Dr. Neelja GuptaConsultan

Wisdom Dental Clinics, Jaipur, India

Guident · Volume 14, Issue 6 (May 2021)Published May 202115 min read19 figures

ABSTRACT

The pathogenicity of covid-19 has various number of consequences striked by immunological changes, ischaemic pneumonia, hypercoagubility, use of high doses of corticosteroids and other numerable factors which are directly linked in development of osteonecrosis.The aim of this review is to analyse the likely consequences of covid-19 upon the mucoskeletal system in covid-19 affected individual presenting with MRONJ i.e medicine related osteonecrosis of jaw.

Key words:MRONJ,covid-19,corticosteroids and osteonecrosis.

INTRODUCTION

Covid-19 is being marked by numerable consequences identified by making immunological changes,hypercoagubility,use of corticosteroids which are interconnected in developing osteonecrosis thus affecting the mucoskeletalsystem.

In the continuation of our previous parts, we have come up with other theory. MRONJ (medicine related osteonecrosis of jaw) is rare but severely impairing condition, of which exact etiology is not yet been determined.1,2 MRONJ is identified by non healing exposed bone in the patient are having history or undergoing use of antiresorptive agent and having no history of radiation exposure.2,3

The very first case of MRONJ reported during early 2000s by Marx in one of the studies based on non-healing exposed bone in maxillofacial region of patient who treated with bisphosphonates,which causes dissolution of bone by affecting its mineral content.4,5 Association between (ONJ) osteonecrosis of jaw and medicines other than the use of bisphosphonates ,denosumab and antiangiogenic drugs which are used to treat malignancy,has been found related with increased incidence of bone necrosis.6

The diagnosing criteria of MRONJ as developed by AAOMS (American association of oral and maxillofacial surgeons) are based upon history of clinical,pharmacological as well as radiographic features.7,5 MRONJ in advanced stages may mimic as the chronic osteomyelitis showing sequestrumformation,thickening of lamina dura as well as pathological fractures.8

Covid -19 doesnot have any therapeutic use of medication recommendation, however use of various antiviral,anticoagulant and corticosteroids is being made for the supportive care.(WHO 2020) Moreover these drugs have restrictions, due to their advere effects in children and renal patients is unknown.9 Osteonecrosis presents with various etiological factors such as;SLE,HIV,hyperbarism,fatembolism,coagulopathies,hyperlipidemia,gaucher’s disease other causes include use of drugs like steroids,alcoholism and smoking.10

Due to its complexity, osteonecrosis is rarely reported in initial stages. Doctors do not diagnose the disease and if do its ‘’wait and watch’’ till the disease reaches to its final stage, though it is important to note that osteonecrosis can be treated in initial stage if diagnosed on time.11,12

After discussing about previous dental complications a case of osteomyelitis in part 1 and diagnosis of thromboembolic event with pilot study in covid -19 suspected cases in our 2nd part here in this case report we further discuss about covid-19 affected individual suspected with MRONJ, thus analysing the consequences of covid-19 in mucoskeletal system.

Therefore, after our suspected cases of osteomyelitis and thromboembolic we further move on in our 3rd part of post covid-19 dental complications here a case of MRONJ is speculated based on its presenting clinical and pathological features.

CASE REPORT

As we have already discussed about our previous cases of osteomyelitis and thromboembolic event related to post coivd-19 infection.Signs and symptoms were almost similar in this case too,except that RT-PCR was negative so to rule out, further tests were carried out to make our diagnosis.Here a 28 year old male patient visited to our clinic with similar complaints as earlier cases.

After examining intraorally it was seen that the patient had multiple small draining sinus along with diffuse gingival oedema,fixed partial denture in both maxillary and mandibular arches. (Figure 1 a,b)

Clinical figure

Figure 1.a,b. Multiple sinus in maxillary arch

Palatal mucosa also presented with oedema.(Figure 2)

Clinical figure

Figure.2 Palatal oedema

Looking at the exact similar signs & symptoms & clinical situation, it was already sure that patient had covid-19 positive history & probably hospitalization also. But to our surprise patient presented with 2 reports of covid-19 done around a month ago after having very mild cough. As reports came out to be negative, he was neither hospitalized nor took any medicines for covid-19.(Figure.3)

Clinical figure

Figure.3 RT-PCR report showing negative result

To futher check for any underlying pathology CECT of face was done which revealed:-

  • erosions with lytic destructions is seen involving alveolar process of maxilla on left side,entire hard palate,medial and lateral pterygoid process
  • ill defined,heterogeneously enhancing soft tissue seen on left side of maxilla and premaxillary region.
  • multiple small lymph nodes are seen at level Ia,Ib,II and III bilaterally,largest one measures approx. 7.2*12 mm at left side at level II
  • mucosal hypertrophy. (Figure 4.)

Clinical figure

Figure 4. CECT report showing mucosal hypertrophy with multiple lymphnode enlargement

Other histopathological and haematological tests were suggested.

In histopathological report:

Specimen of left upper alveolar biopsy revealed- mild acute and chronic inflammatory cell infiltrate giving diagnosis of inflammatory lesion.(Figure.5)

Clinical figure

Figure.5 Histopathology report depicting inflammatory lesion

CBC report showed increase in total leucocyte count to be 11400,neutrophils 3%,haemoglobin 9.8(low) ,RDW-CV 16.6% (Figure.6)

Clinical figure

Figure.6 CBC report showing changes in neutrophil count,haemoglobin and RDW-CV

BT and CT were within normal range (Figure.7)

Clinical figure

Figure.7 BT and CT reports showing results within range

To look for any other comorbid condition random blood glucose was taken which came to be 91mg/dL and Hb1Ac 5.1% (Figure 8a,b)

Clinical figure

Figure 8a. Random blood glucose level is 91mg/dL

Clinical figure

Figure 8b. HbA1C value to be 5.1%

To make it clear if it is a case of malignancy, patient was then adviced to go for biopsy tests for granulation tissue,sinus lining ,bone and necrotic tissue.

  • Specimen of granulation tissue final impression showed: ulceration with marked chronic nonspecific inflammation and histocyteswith no fungus or malignancy(Figure.9a)

Clinical figure

Figure 9a. Biopsy report of granulation tissue showing inflammation with no malignancy

  • sinus lining biopsy showed blood clot with two fragmenets of mucosal tissue lined by respiratory epithelium with no evidence of granuloma or malignancy.(Figure.9b)

Clinical figure

Figure 9b. Biopsy report of sinus lining showing no malignancy

  • biopsy of bone revealed chronic nonspecific suppurative inflammation with no evidence of fungus,granuloma or malignancy.(Figure.9c)

Clinical figure

Figure 9c. Biopsy report of bone showing suppurative inflammation with no malignancy

  • biopsy of necrosed tissue gave impression of congested blood vessels (Figure.9d)

Clinical figure

Figure 9d. Biopsy of necrosed tissue showing congested blood vessels.

Once again after evaluating the patient’s condition with exactly similar clinical, radiological & histopathological findings it was decided to do antibody test, to rule out if patient was asymptomatic carrier & was actually exposed with covid-19 infection or not.

His antibody tests were strongly positive establishing the patient to be a covid -19 asymptomatic carrier. The patient was infected before with covid-19 & presented with strong value of covid-19 antibodies (value came out to be 4.23) (Figure.10)

Clinical figure

Figure 10.Antibodytest for covid-19 value 4.23

Further to be more clear for the diagnosis we thought to go for D-Dimer test who’s value came out to be 0.25mg/dL (Figure.11)

Clinical figure

Figure 11.Showing D-Dimer value as 0.25mg/dL

With our present knowledge & available information, these type of recurrent cases were supposed to be a result of heavy medications after hospitalization (Medication related osteonecrosis of Jaws - MRONJ) or a combination of thromboembolic event, presenting as a complication of post covid-19 infection treatment.

Based upon clinical,histological,radiological and pathological findings treatment was planned and explained to the patient.Surgical debridement and resection of lesion was planned.Extraction of all the teeth were done of affected area along with removal of necrosed tissue to preserve other adjacent teeth and structures.Patient was followed with antibiotic therapy and antimicrobial mouth wash(Figure.12a,b,c)

Clinical figure

Figure 12 a,b,c. Extraction of all teeth and necrosed tissue of affected area

Patient was advised to maintain proper oral hygiene and was recalled with periodic dental visits.Good results were achieved with conservative treatment approach patient showed proper healing of affected area when recalled.(Figure.13 a,b,c)

Clinical figure

Figure 13a,b,c .Showing healing after surgical treatment

The table below is showing suspected cases of dental complications associated with post covid-19 infection with gender predominance.

Clinical figure

TABLE

After discussing about our previous suspected cases of osteomyelitis and thromboembolic event as a complication of post covid-19 infection here we further move on discussing about our another exactly similar case, wherein now with available information & literature, thiscasewas suspected as a result of MRONJ/CRONJi.e medicine/covid related osteonecrosis of jaw.

DISCUSSION

The impact of covid-19 upon various health systems as well as human organs and health economy is evident.According to literature,bone necrosis due to medication is found to be greater than IV administration when compared with oral route.7

The incidence rate of osteonecrosis in antiresorptive user range from 0.7% to 18%.1 In order to include all of the causative medications for diagnosis related to osteonecrosis of jaw (ONJ),AAOMS American association of oral and maxillofacial surgeons suggested a change in nomenclature from Bisphosphonates related ONJ (BRONJ) to MRONJ.6,8 Many studies are evident explaining that oral cavity and its mucosa do play a relevant role in spread of covid-19 virus and its pathogenicity but it is still dubious.13 Our present case also shows paradox regarding the etiology and pathogenicity of bone and soft tissue defect affecting maxilla.

To diagnose a patient of MRONJ two criteria needs to be fulfilled i.e history of ongoing medication with antiangiogenic or antiresorptive such as Bisphosphonates and denosumab other is non healing bone that can be easily probed through fistula in maxillofacial region with no history of radiation of head and neck region or underlying malignancy.1,2,6,7,14 our present case is foundto be previously infected with covid-19,for supportive care must have undergone medications. Biopsy report also do not reveal any kind of malignancy and patient was presenting with draining pus from multiple sinuses.

Looking into the effects of glucocorticoids on bone cells several studies have shown they can induce osteoblast apoptosis and also supress osteoclasts osteoblasts production.Glucocorticoids increase the expression of one of the nuclear factor Kapp B activator receptor (RANKL) and also macrophage colony stimulating factor (M-CSF) and thud decrease expression of osteoprotogerin (OPG) by human osteoblastic and stromal cell in the prepared culture.15,16

Corticosteroids directly damage endothelial cells and thus start the coagulation cascade.17

MRONJ staging system as given by Ruggiero et al in 2006 was subsequently adopted by AAOMS and updated in 2014.6,7

Stage and their Clinical findings are as follows:-

At-risk category: No apparent necrotic bone in patients who have undergone treatment with either oral or IV bisphosphonates

Stage 0: No clinical evidence of necrotic bone, with non-specific clinical findings, radiographic changes, and symptoms

Stage 1: Exposed and necrotic bone, fistulae that probes through the bone in patients who are asymptomatic and have no evidence of underlying infection

Stage 2: Exposed and necrotic bone, or fistulae that probes through the bone, which is associated with infection as evidenced by pain and erythema in the region of exposed bone, with or without purulent drainage

Stage 3: Exposed and necrotic bone or a fistula that probes through the bone in patients with pain, infection, and one or more of the following: exposed and necrotic bone that is extending beyond the region of alveolar bone (i.e., inferior border and ramus in the mandible, maxillary sinus, and zygoma in the maxilla) thus resulting in pathologic fracture, extra-oral fistula, oral-antral/oral-nasal communication or osteolysisthat is extending to the inferior border of the mandible of sinus floor.

The symptoms clinically be manifested as toothache from non odontogeniccause,radiatingpain,unexplained pain along with altered sensation.Radiographically ,it may be an unexplained bone loss attributed to periodontal inflammation thus making changes in trabecular bone pattern.6 Our patient in present case also presented with pain in affected area.

For providing detailed examination,digital imaging such as CT or CBCT provide much higher quality of tomographic images in order to reveal MRONJ lesions.18,19 In our case to make the diagnosis we preferred for digital imaging CECT which showed mucosal hypertrophy with multiple lymphnodes.

Diffuse form of osteosclerosis with bone resorption and degradation of cortical bone, peritoneal reaction and bone fistulas are the findings which reveal the extent of the lesion.20 The diagnostic importance of MRI in ONJ not very well established ,however MRI have the ability to access degree of extent of lesion in bone and soft tissue for planning surgical debridement and resection.14

Various medical conditions can be caused by progression of bone lesions via increase in osteoclast activity5,21,22 MRONJ treatment strategy is not yet established very well,22 therefore case selection with prevention are fundamental in order to reduce the risk of bone necrosis of jaw.5,21,22

Dental screening before any type of ONJ related medication can be a preventive measure to reduce the risk of ONJ.2 The main goal of treatment can be achieved through pain reduction and infection control in addition to bone necrosis and resorption management.2,14

Treatment management of MRONJ is very challenging and also controversial.19,23,24 though treatment protocol is case specific and based on staging and symptoms in ONJ.6 Various treatment modalities has been introduced in order to control ONJ including conservative treatment,surgical debridement and resection of lesion along with other suppurative oxygen therapy to regenerate damaged bone.23,24

After presenting with post covid-19 dental complication cases of osteomyelitis in part 1 and thromboembolic event in part 2,now we move further to our present case which is speculated to be a case of MRONJ, as the patient was infected with covid-19 previously and depicting signs and symptoms of osteonecrosis of jaw based On clinical,pathological and radiological finding it was a suspected case of MRONJ ,so we planned for surgical debridement and resection of necrosed tissue along with extraction of teeth in affected area thus preserving adjacent soft and hard tissue.Later patient was recalled for dental visits and prescribed with antibiotics to prevent any further infection after the surgery and was asked to maintain proper oral hygiene so to get timely healing.The treatment responded well, patient presented with healing of surgical site.

Below flowchart is showing the tests done in order to rule out the suspected dental complication after covid-19 infection.

Clinical figure

In our quest to understand the pathophysiology of this phenomenon associated as a complication or after effect of covid-19 infection, over the past few cases we have ruled out possibility of osteomyelitis, malignancy, fungus, thromboembolic event with culture reports, histopathological examination of necrosed tissue, D-Dimer tests & CT angiography of face.

With the upcoming data & supporting literature favouring the overuse of various combination of different medicines for covid-19 infection, which can be a responsible factor for this condition, known as MRONJ/CRONJ. All the previously encountered patients fit into this theory but this particular patient discussed here presented with negative RT-PCR covid-19 test, though was an asymptomatic carrier (confirmed with strongly positive covid-19 antibody test), which once again ruling out possibility of MRONJ, as this patient was not hospitalized or took any specific medications of covid-19.

This shows that there is some other correlation with covid-19 & this condition where whole maxilla is being affected irreversibly.

Uptill now, there have been some common attributes associated with this condition i.e. – Maxilla, Male, Diabetes

CONCLUSION

Despite there is very strong association between jaw necrosis and medications yet pathophysiology of MRONJ is not entirely known. In light of this,the health practitioners should be aware of the increased use of drugs in covid-19 individuals,as they may encounter a higher number of patients required for dental extractions with increase risk of MRONJ in near future.As in, through this case it shows that there may be some other association of covid-19 distressing whole of the maxilla revealing some common attributes linked with this condition i.emaxilla,male and diabetes.However, further more studies are needed,yetits worth keeping MRONJ in mind.

REFERENCES

  1. Peer A, Khamaisi M. J Dent Res. 2015;94:252–260. Diabetes as a risk factor for medication-related osteonecrosis of the jaw. [PMC free article] [PubMed] [Google Scholar]
  2. Di Fede O, Panzarella V, Mauceri R, et al. Biomed Res Int. 2018;2018:2684924.The dental management of patients at risk of medication-related osteonecrosis of the jaw: new paradigm of primary prevention. [PMC free article] [PubMed] [Google Scholar]
  3. Akashi M, Kusumoto J, Takeda D, Shigeta T, Hasegawa T, Komori T. A literature review of perioperative antibiotic administration in surgery for medication-related osteonecrosis of the jaw. Oral Maxillofac Surg. 2018;22:369–378. [PubMed] [Google Scholar]
  4. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61:1115–1117. [PubMed] [Google Scholar]
  5. Lerman MA, Xie W, Treister NS, Richardson PG, Weller EA, Woo SB. Conservative management of bisphosphonate-related osteonecrosis of the jaws: staging and treatment outcomes. Oral Oncol. 2013;49:977–983. [PubMed] [Google Scholar]
  6. Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O’RyanF.American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg. 2014;72:1938–1956. [PubMed] [Google Scholar]
  7. Ruggiero SL. Bisphosphonate-related osteonecrosis of the jaw (BRONJ): initial discovery and subsequent development. J Oral Maxillofac Surg. 2009;67:13–18. [PubMed] [Google Scholar]
  8. Khan AA, Morrison A, Kendler DL, et al.Case-based review of osteonecrosis of the jaw (ONJ) and application of the international recommendations for management from the International Task Force on ONJ. J ClinDensitom. 2017;20:8–24. [PubMed] [Google Scholar]
  9. Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, BounameauxH, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2016;149(2):315-52.
  10. Ponnusamy KE, Thakkar S, Khanuja HS. Knee Osteonecrosis. In Osteonecrosis. 2014:395-402.
  11. JWM Gardeniers. Treatment of osteonecrosis by joint replacing. Hip Int. 1998;8(3);159-66.
  12. Rijnen WH, Gardeniers JW, Westrek BL, Buma P, Schreus BW, Sugioka's osteotomy for femoral-head necrosis in Young caucasians, IntOrthop. 2005;29(3):140-4.
  13. Pedrosa,M.;Sipert,C.R.;Nogueira,F.N.Salivary glands,Saliva and oral presentations in covid-19 infections.SciELO 2020
  14. McGowan K, McGowan T, Ivanovski S. Oral Dis. 2018;24:527–536.Risk factors for medication-related osteonecrosis of the jaws: a systematic review [PubMed] [Google Scholar]
  15. Golding JS. Hip conditions associated with hemoglobinopathies. ClinOrthopRelat Res. 1973;90:22-8.
  16. Hernigou P, Galacteros F, Bachir D, Goutallier D. Hip deformities in adults with sickle cell disease and a vascular necrosis in childhood. A natural history of fifty-two patients. J Bone Joint Surg Am.1991;73(1):81-92.
  17. Wilson AJ, Murphy WA, Hardy DC, Totty WG. Transient osteoporosis: transient bone marrow edema? Radiology. 1988;167(3):757-60.
  18. Stockmann P, Hinkmann FM, Lell MM, Fenner M, Vairaktaris E, Neukam FW, Nkenke E. Clin Oral Investig. Panoramic Radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study. 2010;14:311–317. [PubMed] [Google Scholar]
  19. Shimamoto H, Grogan TR, Tsujimoto T, et al.Does CBCT alter the diagnostic thinking efficacy, management and prognosis of patients with suspected Stage 0 medication-related osteonecrosis of the jaws? DentomaxillofacRadiol. 2018;47:20170290. [PMC free article] [PubMed] [Google Scholar]
  20. Tsuchimochi M, Kurabayashi T.Symposium: imaging modalities for drug-related osteonecrosis of the jaw (1), role of imaging in drug-related osteonecrosis of the jaw: An up-to-date review (secondary publication) Jpn Dent Sci Rev. 2019;55:1–4. [PMC free article] [PubMed] [Google Scholar]
  21. Voss PJ, Poxleitner P, Schmelzeisen R, Stricker A, Semper-Hogg W. Update MRONJ and perspectives of its treatment. J Stomatol Oral Maxillofac Surg. 2017;118:232–235. [PubMed] [Google Scholar]
  22. Rosella D, Papi P, Giardino R, Cicalini E, Piccoli L, PompaG.Medication-related osteonecrosis of the jaw: clinical and practical guidelines J IntSocPrev Community Dent. 2016;6:97–104. [PMC free article] [PubMed] [Google Scholar]
  23. Lombard T, Neirinckx V, Rogister B, Gilon Y, Wislet S. Stem Cells Int. 2016;2016:8768162. Medication-related osteonecrosis of the jaw: new insights into molecular mechanisms and cellular therapeutic approaches. [PMC free article] [PubMed] [Google Scholar]
  24. Kuroshima S, Sasaki M, Murata H, Sawase T. Gerodontology. 2019;36:313–324.Medicationâ€Ârelated osteonecrosis of the jawâ€Âlike lesions in rodents: a comprehensive systematic review and metaâ€Âanalysis. [PubMed] [Google Scholar]

Disclaimer from Guident

The views and opinions expressed in articles published in Guident are solely those of the authors and do not necessarily reflect the views of the editors, the editorial board or the publisher, Ivory India. Guident does not endorse any product, technique or treatment described. Clinical content is intended for qualified dental and medical professionals and is not a substitute for individual clinical judgement. Guident, its editors and the publisher accept no liability for any consequence arising from the use of information published in the journal.

How to cite this article

Dr. Gaurav Gupta, Dr. D.K. Gupta, Dr. Neelja Gupta. Dental Complications After COVID-19- Understanding the Pathophysiology: Case Series Part-3. Guident. 2021 May;14(6). Available from: https://ivoryindia.in/articles/general/dental-complications-after-covid-19-understanding-the-pathophysiology-case-series-part-3.html

Related articles

More in General

All 212 articles
Vol. 14, Issue 6 · May 2021

Ozone: Natures Filter of Bad Particles

Treatment and prevention is the key to successfully eradicate any disease condition and one such novel therapy which plays a role as a non- invasive therapy in the treatment of various…

Dr. Eeha Chhajer

Call for papers

Publish your clinical work in Guident

Original research, case reports and review articles are welcomed from clinicians and researchers worldwide. Every submission is assessed by the editorial board.